Related Experiment Videos

When Three Isn't a Crowd: A Digyny Concept for Treatment-Resistant, Near-Triploid Human Cancers

Kristine Salmina1, Bogdan I Gerashchenko2, Michael Hausmann3

  • 1Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia.

Genes
|July 24, 2019
PubMed

Insights

Near-triploid tumors may survive radio/chemotherapy via a digyny-like process. Diploid and triploid cells exchange genomes, with triploid cells undergoing pseudo-meiosis to generate diploid and haploid gametes, ensuring tumor survival and variation.

Area of Science:

  • Cancer Biology
  • Genetics
  • Cell Biology

Background:

  • Near-triploid human tumors often exhibit resistance to radio/chemotherapy.
  • The underlying mechanisms for this resistance remain largely unclear.
  • Previous work linked male tumor triploidy to XXY karyotypes.

Purpose of the Study:

  • To propose a conceptual framework for the digyny-like origin of XXY karyotypes in tumors.
  • To investigate genome exchange between diploid and triploid cell populations after DNA damage.
  • To explore the role of pseudo-meiosis in tumor survival and adaptation.

Main Methods:

  • Analysis of primary cancer samples and HeLa cells.
  • Induction of DNA damage and observation of cellular responses.
  • Microscopy to study mitosis and genome segregation.
  • Gene expression analysis focusing on meiotic genes.

Main Results:

  • Diploid and triploid cell subpopulations constitutively coexist and exchange genomes.
  • Genotoxic stress induces endoreduplication and polyploid cell formation.
  • Irradiated triploid HeLa cells can undergo tripolar mitosis, forming diploid sub-subnuclei.
  • Evidence suggests reconstructed diploid cells initiate pseudo-meiosis, producing "gametes".

Conclusions:

  • A digyny-like process involving genome exchange and pseudo-meiosis may explain tumor survival and adaptation.
  • This mechanism promotes DNA repair, genetic variation, and protection against recessive lethal mutations.
  • The findings offer a new perspective on the resistance of near-triploid tumors to cancer therapies.

Related Concept Videos